Adela’s platform demonstrated strong detection for early stage cancers FOSTER CITY, Calif., April 16, 2023 /PRNewswire/ — Adela, Inc. presented data today demonstrating the ability of its genome-wide methylome enrichment platform to detect a broad set of diverse cancers in early stages…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.